Access cutting-edge based on the limited information provided, this appears to be a diagnostic imaging study using a radiotracer. [18f]pi-2620 is typically used for tau protein imaging in neurodegenerative diseases. alzheimer's disease treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Los Angeles location
Access based on the limited information provided, this appears to be a diagnostic imaging study using a radiotracer. [18f]pi-2620 is typically used for tau protein imaging in neurodegenerative diseases. alzheimer's disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related based on the limited information provided, this appears to be a diagnostic imaging study using a radiotracer. [18f]pi-2620 is typically used for tau protein imaging in neurodegenerative diseases. alzheimer's disease treatment provided free
Check if you qualify for this based on the limited information provided, this appears to be a diagnostic imaging study using a radiotracer. [18f]pi-2620 is typically used for tau protein imaging in neurodegenerative diseases. alzheimer's disease clinical trial in Los Angeles, CA
No-Cost Study Care
Local to Los Angeles
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620 for detection of tau deposition in subjects with Alzheimer's disease (AD) and controls during lifetime when compared to histopathology obtained after death and completion of brain autopsy.
Sponsor: Life Molecular Imaging Ltd
Yes, this clinical trial (NCT05641688) has an active research site in Los Angeles, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for based on the limited information provided, this appears to be a diagnostic imaging study using a radiotracer. [18f]pi-2620 is typically used for tau protein imaging in neurodegenerative diseases. alzheimer's disease treatment options in Los Angeles, CA, this clinical trial (NCT05641688) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced based on the limited information provided, this appears to be a diagnostic imaging study using a radiotracer. [18f]pi-2620 is typically used for tau protein imaging in neurodegenerative diseases. alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all based on the limited information provided, this appears to be a diagnostic imaging study using a radiotracer. [18f]pi-2620 is typically used for tau protein imaging in neurodegenerative diseases. alzheimer's disease clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Los Angeles — not just this study.
Browse Leukemia Trials in Los Angeles →